期刊文献+

混合感染对艾滋病抗病毒治疗CD4的影响 被引量:3

Influence of Co-infection on the CD4 in AIDS Following Antiviral Therapy
暂未订购
导出
摘要 目的探讨结核分枝杆菌(TB)、乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)等混合感染对艾滋病患者高效抗反转录病毒治疗(HAART)后CD4的影响,以提高艾滋病合并混合感染的诊断治疗水平。方法对43例HIV/TB、11例HIV/TB/HBV、11例HIV/TB/HCV、5例HIV/TB/HBV/HCV及44例HIV患者,进行HAART,比较治疗前、后的CD4计数的变化;比较治疗后不同时间CD4增加值的变化情况。结果经HAART后各感染组CD4计数不同程度增加,呈向上趋势,治疗后的第6个月CD4达到相对高值,并可维持12个月;治疗后12个月比3、9个月治疗效果更好;各感染组之间CD4计数变化情况无差别。结论各感染组患者经HAART后,CD4计数都有不同程度增加,但各组间之间的差别不大。 Objective To evaluate the influence of tuberculosis(TB),hepatitis B virus(HBV),hepatitis C virus(HCV)and HIV co-infection on the CD4 count after highly active anti-retroviral therapy(HAART),enhance the diagnosis and treatment of AIDS of mixed infection.MethodsThe CD4+T lymphocytes of 43 cases HIV/TB,11 cases HIV/TB/HBV,11 cases HIV/TB/HCV,5 cases HIV/TB/HBV/HCV and 44 cases of HIV patients at different time points after HAART were detected and compared.ResultsThe CD4 count increased after HAART in different degrees,showing an increasing tendency,CD4 count achieved a relatively high value 6 months after treatment,and maintained about 12 months.Compared with treatment after 3,9 months,the effect at 12 months was much better;no difference the changes of CD4 count was among different groups.ConclusionThe CD4 count of infected patients increased in different degrees,however,the difference was not significant.
作者 蒙江明
出处 《广西医学》 CAS 2010年第10期1167-1169,共3页 Guangxi Medical Journal
基金 全球基金中国艾滋病项目(CHN-304-G03-H) 广西南宁市科学研究与技术开发计划项目(200901014C)
关键词 艾滋病 结核病 乙型肝炎 丙型肝炎 CD4 Acquired immune deficiency syndrome Tuberculosis Hepatitis B Hepatitis C CD4+T lymphocytes
  • 相关文献

参考文献10

  • 1曹继军.联合国艾滋病规划署发布《2009年全球艾滋病流行报告》[N].光明日报,2009-11-25(2).
  • 2马建新,王江蓉,沈银忠,张仁芳,刘惜年,江雪艳,孙洪清,卢洪洲.上海地区人类免疫缺陷病毒/艾滋病合并乙型、丙型肝炎病毒感染的临床流行病学研究[J].微生物与感染,2006,1(4):207-210. 被引量:45
  • 3王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:634
  • 4丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:733
  • 5无.慢性乙型肝炎防治指南[J].实用肝脏病杂志,2006,9(1):8-18. 被引量:824
  • 6肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74. 被引量:2915
  • 7张福杰.国家免费艾滋病抗病毒药物治疗手册[M].第2版.北京:人民卫生出版社,2008:98-99.
  • 8Pattanapanyasat K,Thakar MR.CD4+T cell count as a tool to monitor HIV progression & anti-retroviral therapy[J].Indian J Med Res,2005,121(4):539-549.
  • 9Connors M.HIV infection induces changes in CD4^+T-cell phenotype and depletions within the CD4^+T-cell repertoire that are not immediately restored by antiviral or immune-based therapies[J].Nat Med,1997,3(5):533-540.
  • 10Autran B.Positive effects of combined antiretroviral therapy on CD4^+T-cell homeostasis and function in advanced HIV disease[J].Science,1997,277(5 322):112-116.

二级参考文献39

共引文献5107

同被引文献36

  • 1Ignazio Grattagliano,Catia V Diogo,Maria Mastrodonato,Ornella de Bari,Michele Persichella,David QH Wang,Adriana Liquori,Domenico Ferri,Maria Rosaria Carratù,Paulo J Oliveira,Piero Portincasa.A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes[J].World Journal of Gastroenterology,2013,19(20):3007-3017. 被引量:6
  • 2Choi JY,Zhou J,Giles M,et al.Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations:results from APHOD[J].J Acquir Immune Defic Syndr,2011,57(1):e13-e15.
  • 3Gutierrez F,Padilla S,Masia M,et al.Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1year of sucessful antiretroviral therapy[J].Curr HIV Res,2008,6(2):100-107.
  • 4Tan R,Westfall AO,Willig JH,et al.Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy[J].J Acquir Immune Defic Syndr,2008,47(5):553-558.
  • 5Sabin CA,Smith CJ,d'Arminio Monforte A,et al.Response to combination antiretroviral therapy:variation by age[J].AIDS,2008,22(12):1463-1473.
  • 6Szadkowski L,Tseng A,Walmsley SL,et al.Effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy[J].AIDS Res Hum Retroviruses,2012,28(12):1579-1583.
  • 7Miller M,Haley C,Koziel MJ,et al.Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy:a meta-analysis[J].Clin Infect Dis,2005,41(5):713-720.
  • 8Peters L,Mocroft A,Soriano V,et al.Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maxmium virologic suppression[J].J Acquir Immune Defic Syndr,2009,50(5):457-463.
  • 9Sharma SK,Mohan A,Kadhiravan T.HIV-TB co-infection:epidemiology,diagnosis and management[J].Indian J Med Res,2005,121(4):550-567.6.
  • 10Toossi Z,Mayanja-Kizza H,Hirsch CS,et al.Impact of tuberculosis(TB)on HIV-1 activity in dually infected patients[J].Clin Exp Immunol,2001,123(2):233-238.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部